European Journal of Preventive Cardiology · 2013 · 91 citations · 30 references
PharmacyPharmacoeconomicsCost-effectiveness AnalysisBlood Pressure ControlBlood Pressure ManagementBlood Pressure RegulationHypertension ControlHypertension ManagementSelf-managementBlood PressureBlood Pressure MonitoringBlood Pressure Self-managementHypertension Self-managementTelehealth Self-managementTelemonitoring
AIMS: Self-monitoring and self-titration of antihypertensives (self-management) is a novel intervention which improves blood pressure control. However, little evidence exists regarding the cost-effectiveness of self-monitoring of blood pressure in general and self-management in particular. This study aimed to evaluate whether self-management of hypertension was cost-effective. DESIGN AND METHODS: A cohort Markov model-based probabilistic cost-effectiveness analysis was undertaken extrapolating to up to 35 years from cost and outcome data collected from the telemonitoring and self-management in hypertension trial (TASMINH2). Self-management of hypertension was compared with usual care in terms of lifetime costs, quality adjusted life years and cost-effectiveness using a UK Health Service perspective. Sensitivity analyses examined the effect of different time horizons and reduced effectiveness over time from self-management. RESULTS: In the long-term, when compared with usual care, self-management was more effective by 0.24 and 0.12 quality adjusted life years (QALYs) gained per patient for men and women, respectively. The resultant incremental cost-effectiveness ratio for self-management was £1624 per QALY for men and £4923 per QALY for women. There was at least a 99% chance of the intervention being cost-effective for both sexes at a willingness to pay threshold of £20,000 per QALY gained. These results were robust to sensitivity analyses around the assumptions made, provided that the effects of self-management lasted at least two years for men and five years for women. CONCLUSION: Self-monitoring with self-titration of antihypertensives and telemonitoring of blood pressure measurements not only reduces blood pressure, compared with usual care, but also represents a cost-effective use of health care resources.
30
General Cardiovascular Risk Profile for Use in Primary Care
Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina et al. · Circulation · 2008 · 7.5K citations · Full text
Medicine, Cardiology, Risk Analysis +16
Markov Models in Medical Decision Making
Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations
Cardiovascular disease risk profiles
Keaven M. Anderson, Patricia M. Odell, Peter W.F. Wilson et al. · American Heart Journal · 1991 · 2.2K citations · Full text
The Markov Process in Medical Prognosis
J. Robert Beck, Stephen G. Pauker · Medical Decision Making · 1983 · 973 citations
John Bamford, Peter Sandercock, Martin Dennis et al. · Journal of Neurology Neurosurgery & Psychiatry · 1990 · 815 citations · Full text
Medicine, Neurology, Neurosurgery +15